P3 Health Partners [PIII] vs National Healthcare [NHC] Detailed Stock Comparison
P3 Health Partners
NASDAQ
Loading...
National Healthcare
NYSE
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: P3 Health Partners wins in 6 metrics, National Healthcare wins in 11 metrics, with 0 ties. National Healthcare appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | P3 Health Partners | National Healthcare | Better |
|---|---|---|---|
| P/E Ratio (TTM) | -0.18 | 18.11 | P3 Health Partners |
| Price-to-Book Ratio | 0.64 | 1.84 | P3 Health Partners |
| Debt-to-Equity Ratio | 221.06 | 16.83 | National Healthcare |
| PEG Ratio | 0.00 | -1.50 | National Healthcare |
| EV/EBITDA | -0.98 | 11.20 | P3 Health Partners |
| Profit Margin (TTM) | -9.99% | 7.19% | National Healthcare |
| Operating Margin (TTM) | -9.59% | 9.09% | National Healthcare |
| EBITDA Margin (TTM) | N/A | 9.09% | N/A |
| Return on Equity | -141.55% | 10.66% | National Healthcare |
| Return on Assets (TTM) | -24.31% | 5.02% | National Healthcare |
| Free Cash Flow (TTM) | $-110.13M | $79.70M | National Healthcare |
| Dividend Yield | N/A | 2.30% | N/A |
| 1-Year Return | -54.23% | -1.38% | National Healthcare |
| Price-to-Sales Ratio (TTM) | 1.20 | 1.29 | P3 Health Partners |
| Enterprise Value | $225.13M | $1.80B | National Healthcare |
| EV/Revenue Ratio | 0.15 | 1.23 | P3 Health Partners |
| Gross Profit Margin (TTM) | N/A | 39.58% | N/A |
| Revenue per Share (TTM) | $449 | $94 | P3 Health Partners |
| Earnings per Share (Diluted) | $-51.33 | $6.70 | National Healthcare |
| Beta (Stock Volatility) | 0.84 | 0.59 | National Healthcare |
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends
P3 Health Partners vs National Healthcare Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| P3 Health Partners | 1.76% | -11.37% | 1.41% | 35.58% | -0.57% | -30.80% |
| National Healthcare | -0.39% | -4.03% | 8.08% | 11.88% | 30.00% | 13.94% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| P3 Health Partners | -54.23% | -96.42% | -98.23% | -98.23% | -98.23% | -98.23% |
| National Healthcare | -1.38% | 98.89% | 85.59% | 89.80% | 229.32% | 242.71% |
News Based Sentiment: P3 Health Partners vs National Healthcare
P3 Health Partners
News based Sentiment: MIXED
September presented a mixed bag for P3 Health Partners, with positive analyst ratings and a brief stock rally offset by institutional selling and a projected revenue decline. The company is actively engaging with investors, but significant financial challenges remain, creating a high-risk, high-reward investment scenario.
National Healthcare
News based Sentiment: MIXED
October saw significant institutional investment in NHC, which is a positive sign, but this was counterbalanced by a lease default notice and mixed stock performance. The dividend provides stability, but the overall picture is complex, making it a moderately important month for investors.
Performance & Financial Health Analysis: P3 Health Partners vs National Healthcare
| Metric | PIII | NHC |
|---|---|---|
| Market Information | ||
| Market Cap | $1.76B | $1.91B |
| Market Cap Category | Small cap | Small cap |
| 10 Day Avg. Volume | 6,590 | 76,840 |
| 90 Day Avg. Volume | 8,277 | 73,717 |
| Last Close | $8.65 | $121.32 |
| 52 Week Range | $5.80 - $26.00 | $89.14 - $136.86 |
| % from 52W High | -66.73% | -11.35% |
| All-Time High | $16.73 (Dec 06, 2021) | $138.49 (Jul 29, 2024) |
| % from All-Time High | -48.30% | -12.40% |
| Growth Metrics | ||
| Quarterly Revenue Growth | -0.06% | 0.29% |
| Quarterly Earnings Growth | -0.06% | -0.12% |
| Financial Health | ||
| Profit Margin (TTM) | -0.10% | 0.07% |
| Operating Margin (TTM) | -0.10% | 0.09% |
| Return on Equity (TTM) | -1.42% | 0.11% |
| Debt to Equity (MRQ) | 221.06 | 16.83 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $13.60 | $65.93 |
| Cash per Share (MRQ) | $11.81 | $16.62 |
| Operating Cash Flow (TTM) | $-129,955,000 | $149.07M |
| Levered Free Cash Flow (TTM) | $-1,812,750 | $100.15M |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | 2.30% |
| Last 12-Month Dividend | N/A | $2.44 |
Valuation & Enterprise Metrics Analysis: P3 Health Partners vs National Healthcare
| Metric | PIII | NHC |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | -0.18 | 18.11 |
| Forward P/E | -41.19 | 282.14 |
| PEG Ratio | 0.00 | -1.50 |
| Price to Sales (TTM) | 1.20 | 1.29 |
| Price to Book (MRQ) | 0.64 | 1.84 |
| Market Capitalization | ||
| Market Capitalization | $1.76B | $1.91B |
| Enterprise Value | $225.13M | $1.80B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 0.15 | 1.23 |
| Enterprise to EBITDA | -0.98 | 11.20 |
| Risk & Other Metrics | ||
| Beta | 0.84 | 0.59 |
| Book Value per Share (MRQ) | $13.60 | $65.93 |
Financial Statements Comparison: P3 Health Partners vs National Healthcare
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | PIII | NHC |
|---|---|---|
| Revenue/Sales | $373.23M | $373.70M |
| Cost of Goods Sold | N/A | $228.13M |
| Gross Profit | N/A | $145.57M |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | $-38.09M | $30.77M |
| EBITDA | $-16.72M | $43.87M |
| Pre-Tax Income | $-43.17M | $43.72M |
| Income Tax | $1.07M | $11.43M |
| Net Income (Profit) | $-44.25M | $32.29M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | PIII | NHC |
|---|---|---|
| Cash & Equivalents | $40.08M | $90.39M |
| Total Current Assets | $191.44M | $455.20M |
| Total Current Liabilities | $507.03M | $239.23M |
| Long-Term Debt | $117.10M | $163.31M |
| Total Shareholders Equity | $121.08M | $1.01B |
| Retained Earnings | $-523.67M | $774.95M |
| Property, Plant & Equipment | $1.08M | $1.36B |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | PIII | NHC |
|---|---|---|
| Operating Cash Flow | $-43.46M | $47.95M |
| Capital Expenditures | N/A | $-6.14M |
| Free Cash Flow | $-33.47M | $33.12M |
| Debt Repayment | $-341,000 | $-3.00M |
| Common Stock Repurchase | N/A | $-1.72M |
Short Interest & Institutional Ownership Analysis
| Metric | PIII | NHC |
|---|---|---|
| Shares Short | 23,909 | 259,597 |
| Short Ratio | 3.38 | 6.59 |
| Short % of Float | 0.07% | 0.03% |
| Average Daily Volume (10 Day) | 6,590 | 76,840 |
| Average Daily Volume (90 Day) | 8,277 | 73,717 |
| Shares Outstanding | 3.26M | 15.45M |
| Float Shares | 1.23M | 12.46M |
| % Held by Insiders | 0.62% | 0.19% |
| % Held by Institutions | 0.11% | 0.59% |
Dividend Analysis & Yield Comparison: P3 Health Partners vs National Healthcare
| Metric | PIII | NHC |
|---|---|---|
| Last 12-Month Dividend | N/A | $2.44 |
| Last 12-Month Dividend Yield | N/A | 2.30% |
| 3-Year Avg Annual Dividend | N/A | $2.36 |
| 3-Year Avg Dividend Yield | N/A | 0.75% |
| 3-Year Total Dividends | N/A | $7.08 |
| Ex-Dividend Date | N/A | Mar 28, 2025 |